伊格列净L-脯氨酸 L-Proline compd. with (1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol (1:1) 951382-34-6
伊格列净L-脯氨酸
L-脯氨酸与(1S)-1,5-脱水-1-C-[3-(苯并[B]噻吩-2-基甲基)-4-氟苯基]-D-山梨糖醇的化合物;伊格列净脯氨酸;依格列净脯氨酸;伊格列净L-脯氨酸;伊格列净L-脯氨酸盐;L-脯氨酸伊格列净;依格列净L-脯氨酸盐;伊格列净标准品2-L
L-Proline compd. with (1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol (1:1)
L-Prolinecompd.with(1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol(1:1);Ipragliflozin-002-L;L-Prolinecompd.with(1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol(1:1)ChemicalBook;CPD1060;l-prolinecompd;L-prolinecompoundwith(3R,4R,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol(1:1);(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol,(2S)-pyrrolidine-2-carboxylicacid;AzilsartanImpurity62
951382-34-6
C21H21FO5S.C5H9NO2
519.58
溶于二甲基亚砜
Store at -20°C
生物活性
Ipragliflozin L-Proline 是一种口服活性的 SGLT2 的选择性抑制剂，对人SGLT2、大鼠SGLT2和小鼠SGLT2的IC50分别为7.38 nM、6.73 nM和5.64 nM。
